Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar.

Podobne zapisy

• In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.
  od: Hyatt, J M, i wsp.
  Wydane: (1995)
• Impact of MIC Range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the Ceftolozane In Vivo Pharmacokinetic/Pharmacodynamic Target
  od: Lepak, A. J., i wsp.
  Wydane: (2014)
• Accumulation of (99m)Tc-Ciprofloxacin in Staphylococcus aureus and Pseudomonas aeruginosa
  od: Sierra, J. M., i wsp.
  Wydane: (2008)
• Comparative Pharmacodynamics of Gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa
  od: Tam, Vincent H., i wsp.
  Wydane: (2006)
• Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.
  od: Licata, L, i wsp.
  Wydane: (1997)